February 02, 2017 TOULOUSE, France–(BUSINESS WIRE)–Regulatory News: VEXIM (Paris:ALVXM) (FR0011072602 – ALVXM / PEA‐PME eligible), a medical device company specializing in the minimally invasive treatment of vertebral fractures, today announces the expansion of its SpineJack® patent portfolio in Asia. The issuance of new patents in Japan and China further confirms […]

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone